期刊
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
卷 630, 期 8-9, 页码 1258-1262出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/zaac.200400064
关键词
closo-borane; boron neutron capture therapy; targeting; somatostatin; mercaptoundecahydrododecaborate
The non-toxic disodium mercaptoundecahydrododecaborate (BSH) is one of the most promising agents known for boron-neutron-capture therapy (BNCT). In order to enhance the intratumoral concentration of the boron cluster by receptor mediated endocytosis, a synthetic method for the conjugation of borane clusters to peptides was developed. A Michael addition was performed to link BSH to the thiol reactive maleimido modified Tyr(3)-octreotate. Tyr(3)-octreotate, synthesized by Fmoc-solid phase peptide synthesis, is a selective ligand for somatostatin receptors. The modified boron cluster was obtained in 68 % yield after purification. Characterisation of the BSH conjugate was performed with HPLC, MALDI-TOF and electrospray mass spectrometry. The BSH-Tyr(3)-octreotate conjugate is considered to target receptorpositive tumours which might further improve the potential of BNCT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据